Effects of somatostatin analogues on human sphincter of Oddi pressure

Hepatobiliary and Pancreatic Diseases International

Volumn 4, Issue 2, 2005, Pages 302-305

  Wu, Shuo Dong ^a   Zhang, Zhen Hai ^a   Kong, Jing ^a   Li, Yan Jun ^a   Jin, Jun Zhe ^a   Wang, Wei ^a   Li, Dong Yan ^a   Wang, Min Fei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Biliary manometry via choledochofiberoscopy; Sandostatin; Somatostatin; Sphincter of Oddi; Stilamin

Indexed keywords

OCTREOTIDE; SOMATOSTATIN;

ADULT; AGED; ARTICLE; BILE DUCT PRESSURE; CHOLECYSTECTOMY; CHOLEDOCHOTOMY; CLINICAL ARTICLE; CLINICAL TRIAL; COMMON BILE DUCT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESPONSE; DUODENUM; FEMALE; FIBEROSCOPE; HUMAN; INTESTINE PRESSURE; MALE; MANOMETRY; ODDI SPHINCTER; RANDOMIZED CONTROLLED TRIAL; SMOOTH MUSCLE CONTRACTILITY; SURGICAL PATIENT;

ADULT; AGED; CHOLECYSTECTOMY; CHOLEDOCHOLITHIASIS; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL MOTILITY; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MANOMETRY; MIDDLE AGED; OCTREOTIDE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SOMATOSTATIN; SPHINCTER OF ODDI; TREATMENT OUTCOME;

EID: 20344381797     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Toouli J, Di Francesco V, Saccone G, Kollias J, Schloithe A, Shanks N. Division of the sphincter of Oddi for the treatment of dysfunction associated with recurrent pancreatitis. Br J Surg 1996;83:1205-1210.
2. Mariani A, Curioni S, Zanello A, Passaretti S, Masci E, Rossi M, et al. Secretin MRCP and endoscopic pancreatic manometry in the evaluation of sphincter of Oddi function: a comparative pilot study in patients with idiopathic recurrent pancreatitis. Gastrointest Endosc 2003;58:847-852.
3. Maldonado ME, Brady PG, Mamel JJ, Robinson B. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM). Am J Gastroenterol 1999;94:387-390.
4. Loperfido S, Angelini G, Benedetti G, Chilovi F, Costan F, De Beradinis F, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc 1998;48:1-10.
5. Lai KH, Lo GH, Cheng JS, Fu MT, Wang EM, Chan HH. Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis. Gut 2001;49:634-636.
6. Coyle WJ, Pineau BC, Tarnasky PR, Knapple WL, Aabakken L, Hoffman BJ. Evaluation of unexplained acute and acute recurrent pancreatitis using endoscopic retrograde cholangiopancreatography, sphincter of Oddi manometry and endoscopic ultrasound. Endoscopy 2002;34:617-623.
7. Lehman GA. Acute recurrent pancreatitis. Can J Gastroenterol 2003;17:381-383.
8. Testoni PA. Preventing post-ERCP pancreatitis: where are we? JOP 2003;4:22-32.
9. Poon RT, Fan ST. Antisecretory agents for prevention of post-ERCP pancreatitis: rationale for use and clinical results. JOP 2003;4:33-40.
10. Wu SD, Zhang ZH, Jin JZ, Kong J, Wang W, Zhang Q. Effects of narcotic analgesic drugs on human Oddi's sphincter motility. World J Gastroenterol 2004;10:2901-2904.
11. Wu SD, Kong J, Wang W, Zhang Q, Jin JZ. Effect of morphine and M-cholinoceptor blocking drugs on human sphincter of Oddi during choledochofiberscopy manometry. Hepatobiliary Pancreat Dis Int 2003;2:121-125.
12. Huang J, Padbury RT, Schloithe AC, Cox MR, Simula ME, Harvey JR. Somatostatin stimulates the brush-tailed possum sphincter of Oddi in vitro and in vivo. Gastroenterology 1998; 115:672-679.
13. Uemura S, Pompolo S, Furness JB, Hardy KJ. Nitric oxide synthase in neurons of the human gallbladder and its colocalization with neuropeptides. J Gastroenterol Hepatol 1997;12:257-265.
14. Sand J, Tainio H, Nordback I. Peptidergic innervation of human sphincter of Oddi. Dig Dis Sci 1994;39:293-300.
15. Yuan YZ, Zhu Q, Xia L, Zhai ZK, Jiang SH, Xu JY. Effects of somatostatin and emodin on sphincter of Oddi in acute necrotizing pancreatitis in dogs. Chin J Dig 1999;19:252-254.
16. Zou DW, Xu GM, Li ZS, Su ZX, Yin N. Effects of somatostatin on human sphincter of Oddi motility. Chin J Intern Med 1997;36:177-179.
17. Wang CW, Lu XH, Chen YF, Zhou L, Yang CM. Effects of somatostatin and its analogue on canine sphincter of Oddi motility. Natl Med J China 2000;80:621-623.
18. Weber FH Jr, Sears RJ, Kendall B, Pruett TL , Shaffer HA Jr, Yeaton P. Effect of octreotide on human sphincter of Oddi motility following liver transplantation. Dig Dis Sci 1997;42: 1168-1175.
19. Binmoeller KF, Dumas R, Harris AG, Delmont JP. Effect of somatostatin analog octreotide on human sphincter of Oddi. Dig Dis Sci 1992;37:773-777.
20. Di Francesco V, Angelini G, Bovo P, Casarini MB, Filippini M, Vaona B. Effect of octreotide on sphincter of Oddi motility in patients with acute recurrent pancreatitis: a manometric study. Dig Dis Sci 1996;41:2392-2396.